Annette Kleiser
Directeur Général chez Dalan Animal Health, Inc.
Profil
Annette Kleiser is the Chief Executive Officer & Director at Dalan Animal Health, Inc. She previously worked as a Senior Manager-Licensing at Amgen, Inc. and as Vice President-Business Development at Allon Therapeutics, Inc. from 2007 to 2008.
Dr. Kleiser holds a graduate degree from Universität Konstanz and a doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Annette Kleiser
| Sociétés | Poste | Début |
|---|---|---|
Dalan Animal Health, Inc.
 Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Directeur Général | 01/12/2018 |
Anciens postes connus de Annette Kleiser
| Sociétés | Poste | Fin |
|---|---|---|
| ALLON THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2008 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Annette Kleiser
| Universität Konstanz | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dalan Animal Health, Inc.
Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Health Technology |
